AVORAB-20
AVORAB-20 is a premium injectable medication containing Rabeprazole Sodium (20mg) for lyophilized infusion. It is a potent Proton Pump Inhibitor (PPI) designed for the rapid treatment of severe gastrointestinal conditions, such as erosive esophagitis, GERD, and peptic ulcers, where oral administration is not feasible.
Description
AVORAB-20(Rabeprazole Sodium for Injection) is a specialized gastrointestinal treatment designed for patients requiring immediate and effective acid suppression. As a member of the proton pump inhibitor (PPI) class, Rabeprazole works by inhibiting the $H^+/K^+$-ATPase enzyme system (the acid pump) at the secretory surface of the gastric parietal cell, effectively blocking the final step of acid production.
Key Therapeutic Benefits:
-
Rapid Acid Control: Provides faster onset of action compared to many oral PPIs, making it ideal for acute management of hypersecretory conditions.
-
Treatment of GERD: Highly effective for the short-term treatment of Gastroesophageal Reflux Disease (GERD) with a history of erosive esophagitis.
-
Ulcer Management: Aids in the healing and prevention of gastric and duodenal ulcers.
-
Zollinger-Ellison Syndrome: Effective in managing pathological hypersecretory conditions.
Product Specifications:
-
Composition: Each vial contains Rabeprazole Sodium IP 20mg (Lyophilized).
-
Form: Lyophilized powder for reconstitution and intravenous injection.
-
Brand: Avomos Biotech (A division of Sycare Lifesciences).
Usage & Administration:
-
Administration: For Intravenous (IV) use only. The powder must be reconstituted with sterile water or a compatible saline solution as directed.
-
Dosage: As prescribed by a healthcare professional based on the severity of the condition.
-
Storage: Store in a cool, dry place below 25°C. Protect from light. Use the reconstituted solution immediately.
